Academia Meets Industry (AMI) is an organization in support of pharmacy students at the University of Freiburg, Germany. There is an increasing awareness that pharmacy students who are interested in job perspectives in the pharma industry should be connected to this industry as early as possible during their studies.
In this context, AMI offers a “Netzwerkstipendium” to support students within Pharmaceutical Sciences (Master or Staatsexamen) and doctoral researchers at the pharmaceutical institute of the University of Freiburg.
The students within this program will be in close contact with an executive mentor working in the pharmaceutical industry. This person will provide advice to the student, make contacts for them and support them in their career planning. In addition AMI will grant 100€ per month as financial support covering for individual expenses.
Students and doctoral researchers at the faculty of pharmaceutical sciences especially those with an interest in drug development and regulatory affairs are eligible for this program. Participants will be chosen by our organization on an individual basis.
Written application including a vita should not exceed 2 pages. The application (PDF-file) should be sent to . Please also send a printed version to Prof. Dr. Andreas Bechthold, Universität Freiburg, Institut für Pharmazeutische Wissenschaften, Stefan-Meier-Str. 19, 79104 Freiburg
In 2022, the German association for market access, Deutsche Fachgesellschaft für Market Access e.V., rewarded Isabelle Roux, one of our Master students for her Master thesis: Auswirkungen der bedingten Zulassung von Medikamenten auf die Erstattung in der EU.
This is an excellent example for the quality and high topicality of the Master theses within our program. Congrats to Isabelle!
Interview with Prof. Dr. Andreas Bechthold, Executive Director of the Institute of Pharmaceutical Sciences of the Albert-Ludwigs-University of Freiburg, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)
Interview with Prof. Dr. Helmut Laaff , CEO – Institut für Dermatohistology, Pathology, Molecular Pathology, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)
Interview with Daniela Dietz, Head of Regulatory ad Dr. Regenold GmbH, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)